COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,726 Articles (22,502 medRxiv, 8,224 bioRxiv)

Most recent first Previous |  Page 1491: Articles 14901-14910  | Next

SARS-COV-2 Recombinant Receptor-Binding-Domain (RBD) Induces Neutralising Antibodies Against Variant Strains of SARS-CoV-2 and SARS-CoV-1
Law, J. L. M., Logan, M., Joyce, M., Landi, A., Hockman, D., Crawford, K., Johnson, J., LaChance, G., Saffran, H., Shields, J., Hobart, E., Brassard, R., Arutyunova, E., Pabbaraju, K., Croxen, M., Tipples, G., Lemieux, M. J., Tyrrell, D. L., Houghton, M.
10.1101/2021.05.10.443438 — Posted: 2021-05-10
High Dose Convalescent Plasma in COVID-19: Results from the randomized Trial CAPSID
Koerper, S., Weiss, M., Zickler, D., Wiesmann, T., Zacharowski, K., Corman, V. M., Gruener, B., Ernst, L., Spieth, P., Lepper, P. M., Bentz, M., Zinn, S., Paul, G., Kalbhenn, J., Dollinger, M., Rosenberger, P., Kirschning, T., Thiele, T., Appl, T., Mayer, B., Schmidt, M., Drosten, C., Wulf, H., Kruse, J. M., Jungwirth, B., Seifried, E., Schrezenmeier, H.
10.1101/2021.05.10.21256192 — Posted: 2021-05-10
A population-level analysis of the protective effects of androgen deprivation therapy against COVID-19 disease incidence and severity
Lee, K., Heberer, K., Gao, A., Becker, D. J., Loeb, S., Makarov, D., Gulanski, B., Duvall, S., Aslan, M., Lee, J., Hauger, R., Shih, M.-C., Lynch, J., Rettig, M.
10.1101/2021.05.10.21255146 — Posted: 2021-05-10 Discussion: Onsite
A quantitative risk-benefit analysis of ChAdOx1 nCoV-19 vaccine among people under 60 in Italy
Palladino, R., Ceriotti, D., De Ambrosi, D., De Vito, M., Farsoni, M., Seminara, G., Barone-Adesi, F.
10.1101/2021.05.07.21256826 — Posted: 2021-05-10
SARS-CoV-2 Heterogeneity by Ethnicity in Los Angeles
Allan-Blitz, L.-T., Hertlein, F., Klausner, J. D.
10.1101/2021.05.10.21256955 — Posted: 2021-05-10
Characterizing cellular and molecular variabilities of peripheral immune cells in healthy inactivated SARS-CoV-2 vaccine recipients by single-cell RNA sequencing
Tong, R., Zhong, J., Li, R., Chen, Y., Hu, L., Li, Z., Shi, J., Lin, G., Lyu, Y., Hu, L., Guo, X., Liu, Q., Shuang, T., Zhang, C., Yuan, A., Zhang, M., Lin, W., Pu, J.
10.1101/2021.05.06.21256781 — Posted: 2021-05-10
Characterization of the emerging B.1.621 variant of interest of SARS-CoV-2
Laiton-Donato, K., Franco-Munoz, C., Alvarez-Diaz, D. A., Ruiz-Moreno, H., Usme-Ciro, J., Prada, D., Reales, J., Corchuelo, S., Herrera-sepulveda, M., Naizaque, J., Santamaria, G., Rivera, J., Rojas, P., Cardona Rios, A., Hernandez-Ortiz, J., Malo, D., Prieto, F., Ruiz-Gomez, F., Wiesner, M., Ospina-Martinez, M. L., Mercado-Reyes, M.
10.1101/2021.05.08.21256619 — Posted: 2021-05-10
Intra-host evolution provides for continuous emergence of SARS-CoV-2 variants
Landis, J., Moorad, R., Pluta, L. J., Caro-Vegas, C., McNamara, R. P., Eason, A. B., Bailey, A., Villamor, F. C. S., Juarez, A., Wong, J. P., Yang, B., Broussard, G. S., Damania, B., Dittmer, D.
10.1101/2021.05.08.21256775 — Posted: 2021-05-10
The impact of COVID-19 pandemic on the provision of ambulatory care for patients with chronic neurological diseases in Japan: evaluation of an administrative claims database
Sato, K., Mano, T., Niimi, Y., Iwata, A., Toda, T., Iwatsubo, T.
10.1101/2021.05.10.21256951 — Posted: 2021-05-10
Seroprevalence of SARS-CoV-2 antibodies in social housing areas in Denmark
Fogh, K., Eriksen, A. R., Hasselbalch, R. B., Kristensen, E. S., Bundgaard, H., Nielsen, S. D., Joergensen, C. S., Scharff, B. F., Erikstrup, C., Saekmose, S. G., Holm, D. K., Aagaard, B., Norsk, J. B., Nielsen, P. B., Kristensen, J. H., Oestergaard, L., Ellermann-Eriksen, S., Andersen, B., Nielsen, H., Johansen, I. S., Wiese, L., Simonsen, L., Fischer, T. R., Folke, F., Lippert, F., Ostrowski, S. R., Ethelberg, S., Koch, A., Vangsted, A.-M., Krause, T. G., Formsgaard, A., Nielsen, C., Ullum, H., Skov, R., Iversen, K.
10.1101/2021.05.07.21256725 — Posted: 2021-05-10

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).